Press Resease

Cognitive and Memory Enhancer Drugs Market by Drug Type (Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others) and Application (Disease Treatment, Academic Performance, Athletic Performance and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 –2024

Published Date: 16-Oct-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3429 Status : Published

Global cognitive and memory enhancer drugs market expected to reach around USD 6.98 billion by 2024, growing at a CAGR of 8.7 % between 2018 and 2024. Smart drugs and cognitive enhancers are drug substances that improve cognitive function, memory, and creativity in healthy individuals.

Description

The report covers forecast and analysis for the cognitive and memory enhancer drugs market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the cognitive and memory enhancer drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cognitive and memory enhancer drugs market on a global level.

In order to give the users of this report a comprehensive view of the cognitive and memory enhancer drugs market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study includes a market attractiveness analysis of all the segments related to the market.

Global Cognitive and Memory Enhancer Drugs Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the cognitive and memory enhancer drugs market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2025. 

By drug type, the global cognitive and memory enhancer drugs market is divided into Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others. Among these products, insulin is expected to account for the largest share of the market. By application segment global cognitive and memory enhancer drugs market is divided into disease treatment, academic performance, athletic performance, and others. 

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for cognitive and memory enhancer drugs based on individual segment and applications in all the regions and countries.

Some of the key players in cognitive and memory enhancer drugs market include Pfizer Inc., Eisai Co., Ltd., Allergan, Inc., Novartis AG, Shire, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AlternaScript LLC, Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.), and Ceretropic.

This report segments the global cognitive and memory enhancer drugs market as follows:

Global Cognitive and Memory Enhancer Drugs Market: Drug Segment Analysis

  • Aricept
  • Exelon
  • Namenda
  • Razadyne
  • Provigil
  • Ritalin
  • Adderall
  • Others

Global Cognitive and Memory Enhancer Drugs Market: Application Segment Analysis

  • Disease Treatment
  • Academic Performance
  • Athletic Performance
  • Others

Global Cognitive and Memory Enhancer Drugs Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Cognitive and Memory Enhancer Drugs Market, 2015 - 2025 (USD Billion)
    • 2.2. Global Cognitive and Memory Enhancer Drugs Market: Snapshot
  •  
  • Chapter 3. Cognitive and Memory Enhancer Drugs Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Cognitive and Memory Enhancer Drugs Market drivers: Impact analysis
      • 3.2.2. Growing prevalence of Neurological diseases
      • 3.2.3. Rising geriatric population
    • 3.3. Market Restraints
      • 3.3.1. Lack of awareness among consumers
      • 3.3.2. Contradictions on efficacy and efficiency of cognitive and memory enhancer drugs are expected to hamper growth of market
    • 3.4. Opportunities
      • 3.4.1. Untapped Markets
      • 3.4.2. The increasing emphasis of key players on research and development activities
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Drug Type
      • 3.6.2. Market attractiveness analysis, by Application Type
      • 3.6.3. Market attractiveness analysis, by Regional segment
  •  
  • Chapter 4. Global Cognitive and Memory Enhancer Drugs Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Cognitive and Memory Enhancer Drugs market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Cognitive and Memory Enhancer Drugs Market - Drug Type Segment Analysis
    • 5.1. Global Cognitive and Memory Enhancer Drugs market: Drug Type overview
      • 5.1.1. Global Cognitive and Memory Enhancer Drugs market revenue share, by Drug Type, 2015 and 2025
      • 5.1.2. Global Cognitive and Memory Enhancer Drugs market revenue share, by Aricept, 2015 - 2025
      • 5.1.3. Global Cognitive and Memory Enhancer Drugs market revenue share, by Exelon, 2015 - 2025
      • 5.1.4. Global Cognitive and Memory Enhancer Drugs market revenue share, by Namenda, 2015 - 2025
      • 5.1.5. Global Cognitive and Memory Enhancer Drugs market revenue share, by Razadyne, 2015 - 2025
      • 5.1.6. Global Cognitive and Memory Enhancer Drugs market revenue share, by Provigil, 2015 - 2025
      • 5.1.7. Global Cognitive and Memory Enhancer Drugs market revenue share, by Ritalin, 2015 - 2025
      • 5.1.8. Global Cognitive and Memory Enhancer Drugs market revenue share, by Adderall, 2015 - 2025
      • 5.1.9. Global Cognitive and Memory Enhancer Drugs market revenue share, by Others, 2015 - 2025
  •  
  • Chapter 6. Global Cognitive and Memory Enhancer Drugs Market - Application Segment Analysis
    • 6.1. Global Cognitive and Memory Enhancer Drugs Market: Application overview
      • 6.1.1. Global Cognitive and Memory Enhancer Drugs market revenue share, Application, 2015 and 2025
      • 6.1.2. Global Cognitive and Memory Enhancer Drugs market for Disease Treatment, 2015 - 2025(USD Billion)
      • 6.1.3. Global Cognitive and Memory Enhancer Drugs market for Academic Performance, 2015 - 2025(USD Billion)
      • 6.1.4. Global Cognitive and Memory Enhancer Drugs market for Athletic Performance, 2015 - 2025(USD Billion)
      • 6.1.5. Global Cognitive and Memory Enhancer Drugs market for Others, 2015 - 2025(USD Billion)
  •  
  • Chapter 7. Global Cognitive and Memory Enhancer Drugs Market - Regional Segment Analysis
    • 7.1. Global Cognitive and Memory Enhancer Drugs market: Regional overview
      • 7.1.1. Global Cognitive and Memory Enhancer Drugs market revenue share, by region, 2015 and 2025
    • 7.2. North America
      • 7.2.1. North America Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
      • 7.2.2. North America Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.2.3.2. U.S. Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
      • 7.3.2. Europe Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.3.3. U.K.
        • 7.3.3.1. U.K. Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.3.3.2. U.K. Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.3.4.2. Germany Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.3.5.2. France Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
      • 7.4.2. Asia Pacific Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.4.3.2. China Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.4.4.2. Japan Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.4.5.2. India Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
      • 7.5.2. Latin America Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
        • 7.5.3.2. Brazil Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa Cognitive and Memory Enhancer Drugs market revenue, by Drug Type, 2015 - 2025(USD Billion)
      • 7.6.2. Middle East and Africa Cognitive and Memory Enhancer Drugs market revenue, by Application, 2015 - 2025(USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Pfizer Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Eisai Co., Ltd.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Allergan, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Novartis AG
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Shire
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Johnson & Johnson
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Takeda Pharmaceutical Company Limited
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. AlternaScript LLC
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.)
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Ceretropic
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments

Methodology

Free Analysis

In the last few decades, many pharmacological treatments focused and aimed at improving the cognitive function of the brain in different brain disorders have been explored and has become vital in neurological disorders. Cognitive and memory enhancer drugs are widely being used in the treatment of developmental, neurodegenerative conditions such as attention deficit hyperactivity disorder, Alzheimer’s disease, and Parkinson’s disease. Apart from the key use in disease treatment, many people are using cognitive and memory enhancer’s drugs to improve memory, mental alertness concentration, and to boost energy levels. There are many different cognitive enhancers available in the market under different brand names for different disease applications. Rising popularity and a continued consumer shift towards enhancer drugs usage are driving the growth of the cognitive and memory enhancer drugs market. 

Primary factors responsible for the growth of cognitive and memory enhancer drugs market are increasing geriatric population and prevalence of neurological & memory-related disorders around the world. Spurring demand for memory enhancer in the treatment of psychological conditions such as dementia, schizophrenia is driving the growth of global cognitive and memory enhancer drugs market. Moreover, growing awareness regarding cognitive and memory enhancer drugs and increasing medical expenditure in developing countries is accelerating the growth of the market. However, ethical issues may hinder the growth of global cognitive and memory enhancer drugs market. On the other hand, factors such as increasing focus of key players on  raising efficiency of cognitive drugs and ongoing research activities in novel drug production, untapped market potential in developing countries, potential drugs under pipeline, and clinical trials are expected to generate lucrative opportunities in the cognitive and memory enhancer drugs market  during forecast period.

Global Cognitive and Memory Enhancer Drugs Market

By drug type, the global cognitive and memory enhancer drugs market is divided into Aricept, Namenda, Provigil, Ritalin, Razadyne, Adderall, Exelon, and others. Namenda drug was the major revenue grosser in 2017. Ritalin was the fastest growing segment in 2017 and is expected to grab a large chunk of total revenue in the coming years.

By application segment global cognitive and memory enhancer drugs market is divided into disease treatment, academic performance, athletic performance, and others. Disease segment accounted largest revenue share in 2017, owing to the high acceptance of cognitive and memory enhancers drugs in neurological diseases treatment. The academic performance segment was the fastest growing segment and is anticipated to grow at the highest CAGR during the forecast period.

Based on the geography, the global cognitive and memory enhancer drugs market is divided into five regions, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant region in terms of revenue generation over the forecast period followed by Europe. The Asia Pacific, on the other hand, was the fastest growing market with the highest year on year growth rate. The Middle East and Africa & Latin America are expected to experience slow growth in the cognitive and memory enhancer drugs market in the years to come. 

 Some of the key players in cognitive and memory enhancer drugs market include Pfizer Inc., Novartis AG, Allergan, Inc., Shire, Eisai Co., Ltd., Johnson & Johnson, AlternaScript LLC, Takeda Pharmaceutical Company Limited, Cephalon, Inc., and Ceretropic.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com